STAR Pharmaceutical Limited announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced Revenue was CNY 85.683 million compared to CNY 35.799 million a year ago. Loss from operations was CNY 772,000 compared to CNY 30.398 million a year ago. Loss for the period/year was CNY 70,000 compared to CNY 28.637 million a year ago. Basic loss per share was CNY 0.0015 compared to CNY 0.6159 a year ago. For the full year, Revenue was CNY 241.747 million compared to CNY 93.321 million a year ago. Profit from operations was CNY 7.102 million compared to Loss from operations of CNY 20.470 million a year ago. Profit for the period/year was CNY 9.658 million compared to loss for the period/year of CNY 20.845 million a year ago. Basic earnings per share was CNY 0.208 compared to basic loss per share of CNY 0.4476 a year ago.